Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with paroxysmal atrial fibrillation (an irregular heartbeat that comes and goes) and are experiencing symptoms from it, where their doctor considers them a suitable candidate for a catheter ablation procedure (a procedure to correct the irregular heart rhythm)
- People for whom at least one heart rhythm medication (from a specific class of drugs used to control irregular heartbeats) has not worked, has caused unacceptable side effects, was not wanted, or is not safe for them to take
- People who are willing and able to give their informed consent to participate
- People who are able and willing to attend and complete all required appointments and tests before, during, and after the trial
Who may not be able to join:
- People who have previously been diagnosed with a longer-lasting form of atrial fibrillation that has continued for more than 7 days without returning to a normal rhythm on its own
- People who have previously had a catheter-based or surgical procedure to treat their atrial fibrillation
- People who have a significant birth defect or other medical condition that, in their doctor's opinion, would make a catheter ablation procedure unsafe for them
- People who are currently participating in another clinical trial testing a different medical device or drug
- People whose life expectancy is estimated to be less than 12 months
- People who have any other contraindications (reasons a treatment would be unsafe) as outlined in the trial protocol (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Biosense Webster, Inc. Clinical Trial, Biosense Webster, Inc.
Phone: +1 949 230 3701
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Occurences of Early Onset Primary Adverse Events (PAEs) Within 7 days of the Index Ablation Procedure; Freedom From Documented (Symptomatic and Asymptomatic) Atrial Tachyarrhythmias Episodes
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.